esmolol has been researched along with Cardiovascular Diseases in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (26.67) | 18.7374 |
| 1990's | 3 (20.00) | 18.2507 |
| 2000's | 4 (26.67) | 29.6817 |
| 2010's | 4 (26.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, QH; Hu, Q; Wang, WX; Zhang, XK | 1 |
| Birkenhäger, TK; Boere, E; Groenland, TH; van den Broek, WW | 1 |
| Davis, A; McCafferty, J; McCall, WV; Rosenquist, PB; Simmons, T; Zisselman, M | 1 |
| Boer, C; Bouwman, RA; Bulte, CS; Geersing, PG; Loer, SA; Stek, ML; Viersen, VA | 1 |
| Haney, JS; Wiest, DB | 1 |
| Bahk, JH; Do, SH; Ham, BM; Kim, CS; Lim, YJ | 1 |
| Boldt, J; Suttner, S | 1 |
| Birkenhäger, TK; Bruijn, JA; Groenland, TH; Kusuma, A; Mulder, PG; Pluijms, EM; van den Broek, WW | 1 |
| Wiest, D | 1 |
| Parr, MJ | 1 |
| Brody, SL; Sand, IC; Slovis, CM; Wrenn, KD | 1 |
| Pollan, S; Tadjziechy, M | 1 |
| Laddu, AR; Singh, BN | 1 |
| Benfield, P; Sorkin, EM | 1 |
| Frishman, WH; Murthy, S; Strom, JA | 1 |
8 review(s) available for esmolol and Cardiovascular Diseases
| Article | Year |
|---|---|
Beta-blocking agents during electroconvulsive therapy: a review.
Topics: Adrenergic beta-Antagonists; Cardiovascular Diseases; Electroconvulsive Therapy; Humans; Labetalol; Morpholines; Propanolamines; Randomized Controlled Trials as Topic; Urea | 2014 |
Clinical pharmacokinetics and therapeutic efficacy of esmolol.
Topics: Adrenergic beta-1 Receptor Antagonists; Cardiovascular Diseases; Humans; Perioperative Care; Propanolamines | 2012 |
Combined use of ultra-short acting beta-blocker esmolol and intravenous phosphodiesterase 3 inhibitor enoximone.
Topics: Adrenergic beta-Antagonists; Animals; Cardiovascular Diseases; Drug Therapy, Combination; Enoximone; Humans; Infusions, Intravenous; Phosphodiesterase Inhibitors; Propanolamines; Time Factors | 2007 |
[Beta-blockers and electroconvulsive therapy: a review].
Topics: Adrenergic beta-Antagonists; Blood Pressure; Cardiovascular Diseases; Dose-Response Relationship, Drug; Electroconvulsive Therapy; Heart Rate; Humans; Propanolamines; Randomized Controlled Trials as Topic; Seizures; Time Factors | 2008 |
Esmolol. A review of its therapeutic efficacy and pharmacokinetic characteristics.
Topics: Blood Pressure; Cardiovascular Diseases; Drug Interactions; Drug Tolerance; Heart Rate; Humans; Propanolamines | 1995 |
Esmolol: a novel ultra-short acting beta-adrenoreceptor blocking agent.
Topics: Adrenergic beta-Antagonists; Cardiovascular Diseases; Humans; Propanolamines | 1986 |
Esmolol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.
Topics: Adrenergic alpha-Antagonists; Cardiovascular Diseases; Humans; Kinetics; Propanolamines | 1987 |
Ultra-short-acting beta-adrenergic blockers.
Topics: Adrenergic beta-Antagonists; Cardiovascular Diseases; Fluorobenzenes; Humans; Hypotension; Propanolamines | 1988 |
3 trial(s) available for esmolol and Cardiovascular Diseases
| Article | Year |
|---|---|
The effect of continuous perfusion of esmolol on cardiovascular risk in elderly patients undergoing noncardiac surgery.
Topics: Adrenergic beta-1 Receptor Antagonists; Aged; Aged, 80 and over; Cardiovascular Diseases; Female; Follow-Up Studies; Gastrointestinal Neoplasms; Humans; Intubation, Intratracheal; Laparoscopy; Male; Middle Aged; Oxygen Consumption; Postoperative Complications; Propanolamines; Risk Factors; Time Factors | 2017 |
Clinical trial of esmolol-induced controlled hypotension with or without acute normovolemic hemodilution in spinal surgery.
Topics: Adrenergic beta-Antagonists; Aged; Blood Loss, Surgical; Blood Pressure; Cardiac Output; Cardiovascular Diseases; Decompression, Surgical; Female; Heart Rate; Hemodilution; Hemodynamics; Humans; Hypotension, Controlled; Male; Middle Aged; Oxygen Consumption; Propanolamines; Spinal Cord; Spinal Fusion | 2003 |
Experience with esmolol for the treatment of cocaine-associated cardiovascular complications.
Topics: Adrenergic beta-Antagonists; Adult; Cardiovascular Diseases; Cocaine; Emergency Service, Hospital; Female; Georgia; Hemodynamics; Hospitals, Teaching; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Middle Aged; Propanolamines; Substance-Related Disorders | 1991 |
4 other study(ies) available for esmolol and Cardiovascular Diseases
| Article | Year |
|---|---|
Electroconvulsive therapy in the setting of implantable cardioverter-defibrillators.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Arrhythmias, Cardiac; Bipolar Disorder; Cardiovascular Diseases; Coronary Artery Disease; Defibrillators, Implantable; Depressive Disorder, Major; Electroconvulsive Therapy; Female; Humans; Male; Middle Aged; Propanolamines | 2009 |
Beat-to-beat hemodynamic monitoring during electroconvulsive therapy.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Anesthesia, General; Blood Pressure; Cardiac Output; Cardiovascular Diseases; Data Interpretation, Statistical; Electrocardiography; Electroconvulsive Therapy; Female; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Monitoring, Physiologic; Parasympathetic Nervous System; Propanolamines; Prospective Studies; Risk; Stroke Volume; Sympathetic Nervous System; Young Adult | 2011 |
Cocaine dosage in rhinosurgery.
Topics: Adrenergic beta-Antagonists; Cardiovascular Diseases; Cocaine; Humans; Labetalol; Propanolamines | 1993 |
Esmolol in the management of epinephrine- and cocaine-induced cardiovascular toxicity.
Topics: Adrenergic beta-Antagonists; Cardiovascular Diseases; Cocaine; Epinephrine; Humans; Male; Middle Aged; Nasal Polyps; Propanolamines | 1989 |